| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes | CHI-YUAN YAO ; Chen, Ching-Hsuan; HUAI-HSUAN HUANG ; HSIN-AN HOU ; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Kao, Chein-Jun; TZU-PIN LU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood advances | 15 | 13 | |
| 2021 | Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan – a population-based study | HUAI-HSUAN HUANG ; FEI-YUAN HSIAO ; Chen H.-M.; Wang C.-Y.; BOR-SHENG KO | British Journal of Haematology | 6 | 6 | |
| 2022 | Blood cell and marrow changes in patients with Kikuchi disease | SHAN-CHI YU ; HUAI-HSUAN HUANG ; CHUN-NAN CHEN ; TSENG-CHENG CHEN ; TSUNG-LIN YANG | Haematologica | 1 | 1 | |
| 2023 | Bone Marrow Histology in Hemophagocytic Lymphohistiocytosis | SHAN-CHI YU ; Chieh-Lung Cheng ; HUAI-HSUAN HUANG ; Lo, Hsiao-Ting; Liu, Yu-Jung; Hsieh, Han-Peng; Chao, Hsiao-Ling; Wang, Yi-Hua; Hsu, Cheng-An; Teng, Shu-Chun | Archives of pathology & laboratory medicine | 2 | 1 | |
| 2022 | Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study | Wang Y.-H.; FENG-MING TIEN ; Tsai C.-H.; HUAI-HSUAN HUANG ; JIA-HAU LIU ; Liao X.-W.; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO | Cancer Reports | 1 | 1 | |
| 2009 | Case report: First case of granulomatous amebic encephalitis caused by Acanthamoeba castellanii in Taiwan | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; HUAI-HSUAN HUANG ; Liang S.-Y.; Cheng Y.-J.; Ji D.-D.; SHAN-CHWEN CHANG | American Journal of Tropical Medicine and Hygiene | 25 | 24 | |
| 2017 | Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase | SHAN-CHI YU ; HUAI-HSUAN HUANG ; Li C.-C.; JIH-LUH TANG ; Lee Y.-H.; TSUI-LIEN MAO ; KUAN-TING KUO ; Lin C.-T.; JIA-HAU LIU ; BOR-SHENG KO ; MING YAO | Biology of Blood and Marrow Transplantation | 1 | 1 | |
| 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 46 | 43 | |
| 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 171 | 160 | |
| 2021 | Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO | International Journal of Clinical Practice | 7 | 6 | |
| 2022 | The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan | HUAI-HSUAN HUANG ; Chen C.-M.; Wang C.-Y.; Hsu W.W.-Y.; Chen H.-M.; BOR-SHENG KO ; FEI-YUAN HSIAO | PLoS ONE | 4 | 4 | |
| 2020 | False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration | WANG-DA LIU ; SHU-WEN LIN ; Shih, M. C.; Su, C. L.; Wang, Y. W.; Lin, S. C.; Lee, Y. F.; HUAI-HSUAN HUANG ; WEN-CHIEN CHOU ; UN-IN WU ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Clinical Microbiology and Infection | 10 | 8 | |
| 2020 | Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: A population-based study in Taiwan, 2010-2015 | HUAI-HSUAN HUANG ; BOR-SHENG KO ; Chen H.-M.; Chen L.-J.; Wang C.-Y.; Hsiao F.-Y.; FEI-YUAN HSIAO ; FEI-YUAN HSIAO ; FEI-YUAN HSIAO | Immunity and Ageing | 5 | 5 | |
| 2019 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome | HUAI-HSUAN HUANG ; Chen F.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; BOR-SHENG KO ; Lin C.-T.; JIH-LUH TANG ; Li C.-C.; MING YAO ; WOEI TSAY ; SZU-CHUN HSU ; SHANG-JU WU ; Chen, Chien-Yuan ; SHANG-YI HUANG ; Tseng M.-H.; HWEI-FANG TIEN ; Chen R.-H. | BMC Cancer | 37 | 32 | |
| 2022 | Management of metastatic renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy: A real-world retrospective study from Taiwan | Chung H.-J.; Chang Y.-H.; Huang Y.-H.; Lin T.-P.; Wei T.-C.; FANG-JU LIN ; HUAI-HSUAN HUANG ; Wang H.-C. | Journal of the Chinese Medical Association : JCMA | 4 | 3 | |
| 2021 | Real-World Outcomes of Patients with Acute Myeloid Leukemia in Taiwan: A Nationwide Population-Based Study, 2011-2015 | Wang C.-Y.; HUAI-HSUAN HUANG ; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Clinical Lymphoma, Myeloma and Leukemia | 0 | 0 | |
| 2018 | Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry Database | HUAI-HSUAN HUANG ; Wen Y.-C.; Chen H.-M.; FEI-YUAN HSIAO ; BOR-SHENG KO | Cancer Medicine | 5 | 5 | |
| 2018 | Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012 | BOR-SHENG KO ; Chen L.-J.; HUAI-HSUAN HUANG ; Wen Y.-C.; Liao C.-Y.; Chen H.-M.; FEI-YUAN HSIAO | Cancer Medicine | 9 | 8 | |
| 2021 | Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study | Chen, Mei-Tsen; Huang, Shih-Tsung; Lin, Chih-Wan; BOR-SHENG KO ; WEN-JONE CHEN ; HUAI-HSUAN HUANG ; FEI-YUAN HSIAO | The oncologist | 5 | 5 | |
| 2019 | Women with diffuse large B cell lymphoma benefit more from rituximab-containing chemotherapy | HUAI-HSUAN HUANG ; FEI-YUAN HSIAO ; Chen L.-J.; Chen H.-M.; BOR-SHENG KO | Journal of Women's Health | 5 | 6 | |
